Form 4 for KPTI Karyopharm Therapeutics Inc.
Accepted 2022-02-09 00:00:00 ET · period of report 2022-02-07 · accession 0001209191-22-008130 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-02-09 | 2022-02-07 | KPTI | Shah Jatin | EVP, Chief Medical Off | S - Sale | $9.86 | -1,704 | 130.8K | -1% | -$16.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-02-07 | S | D | 1,704 | $9.86 | 130,756 | D | — | — | (F2) The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on February 7, 2022 on behalf of a group of employees of Karyopharm Therapeutics Inc. to satisfy the payment of withholding tax liability of such employees. (F3) Includes 1,323 shares acquired under the Karyopharm Therapeutics Inc. 2013 Employee Stock Purchase Plan on October 31, 2021. |